NSE · SUVEN
Suven Life Sciences Limited
₹342.35
+4.87%
Market Cap
9,028.45 Cr
P/E Ratio
-28.22
P/B Ratio
15.26
ROE
-46.73%
ROCE
-46.55%
Dividend Yield
—
52W High
₹344.65
52W Low
₹125.45
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 3.57 Cr | 1.52 Cr |
| Net Profit | -127.61 Cr | -45.60 Cr |
| EPS | -4.84 | -2.02 |
| Operating Profit | -127.13 Cr | -45.44 Cr |
Shareholding pattern
Promoter
65.47%
Public
34.53%
FII
—
DII
—
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 30 Jul 2024 | Other | Annual General Meeting |
| 02 Aug 2023 | Other | Annual General Meeting |
| 17 Oct 2022 | Rights | Rights 1:2 @ Premium Rs 54/- |
| 29 Jul 2022 | Other | Annual General Meeting |
| 02 Aug 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.